Genpact Stock Plummets to New 52-Week Low at $26.85

Genpact has reached a new 52-week low, trading at USD 26.85 as of June 30, 2026. This marks a significant decline for the small-cap company, which has seen a one-year performance drop of 16.36%, contrasting sharply with the S&P 500's gain of 20.86% during the same period. Despite the recent price decline, Genpact maintains a market capitalization of USD 6,250 million and exhibits strong management efficiency, reflected in a return on equity of 22.53%. The company also boasts a low debt-to-equity ratio of 0.16, indicating a conservative approach to leverage. In terms of profitability, Genpact has shown resilience with an operating profit growth rate of 10.73% annually. Recent financial results highlight a peak operating cash flow of USD 649.51 million and a dividend per share of USD 3.95, showcasing its commitment to returning value to shareholders. While the stock is currently trading at a discount compared to its peers' historical valuations, the overall performance metrics suggest a complex landscape for Genpact as it navigates these market conditions.